Morana Jovan-Embiricos Managing Partner, F2 Ventures

Morana Jovan-Embiricos is on the Board of Directors of Orna Therapeutics and is the founder of F2 Ventures.

Morana has extensive experience in both the public and private biotechnology equity markets through a series of funds launched at F2 since 2003. She has also successfully managed a biotech allocation for one of the largest hedge funds in the US.

Prior to F2, Morana was a Partner with MPM BioImpact Capital working both on the investment side and directly with portfolio companies to help them attain critical business development milestones and securing appropriate exits either through trade sale or an IPO. She also led life science activities at Banque Syz & Co in Geneva, launching one of the first long only biotech funds in Switzerland. She is a member of the Board of Damon Runyon Cancer Research Foundation.

Morana holds an Executive Business Program from Stanford-National University of Singapore and was a post-doctoral fellow at Harvard University having worked on protein un-caging in the Department of Developmental Biology. She received her PhD in Biophysical Chemistry from the University of Cambridge.

Morana currently serves on the Board of Directors of AlloVir, ElevateBio and Cullinan Management.